In models of breast cancer bone metastasis, IGF-1 ligand promotes motility of bone-metastatic cells through IGF-IR activation [17], and bone-derived IGF-1 can activate the process of bone metastases in breast cancer in a paracrine manner [18]. This evidence concerns the gene IGF1 and breast carcinoma.